Roll up your sleeves regularly to support blood cancer patients
Monday, 10 June 2019
The Leukaemia Foundation is challenging more Australians to step up and become one of the 18 monthly blood donors it takes to treat just one person living with blood cancer this National Blood Donor Week.
More than 100,000 Australians are currently affected by blood cancer, and Leukaemia
Leukaemia Foundation celebrates National Volunteer Week 2019
Volunteer drivers who take blood cancer patients to and from vital medical appointments last year travelled more than 1.5 million kilometres, the equivalent of driving 37 times around the world.
It’s a service the Leukaemia Foundation’s General Manager of People Living with Blood Cancer Emma Craig said could not be
Leukaemia Foundation supports Australian Research Innovation
The Leukaemia Foundation has confirmed it will fund priority-driven blood cancer research in some of Australia’s leading research centres through an $800,000 grant to Cancer Australia.
Five innovative projects will benefit from the funding through the Leukaemia Foundation’s ongoing partnership with Cancer Australia – an Australian Government agency that provides
May is Myeloma Awareness Month
Five Australians will be told today they have the blood cancer myeloma.
The Leukaemia Foundation, in conjunction with Myeloma Australia, will host free educational seminars across Australia as part of Myeloma Awareness Month this May, as it commits to raising more awareness around the disease, which saw a 35 per
Leukaemia Foundation supports better access to clinical trials for all Australians
Friday, 3 May 2019
The Leukaemia Foundation says recent commitments from each major political party to support better access to clinical cancer trials are a pivotal step toward improving outcomes for Australians living with blood cancers.
The Leukaemia Foundation has welcomed the latest $100 million commitment from the Federal Government to
Federal Health Minister Greg Hunt commits to Blood Cancer Taskforce and Action Plan
Wednesday, 17 April 2019
The Leukaemia Foundation welcomes the commitment from the Federal Health Minister Greg Hunt to establish a Blood Cancer Taskforce and Action Plan.
The Blood Cancer Taskforce will work with leading clinicians, researchers and patient groups in the blood cancer community to
Leukaemia Foundation supports Labor’s $20 million blood cancer Right to Trial
Wednesday, 17 April 2019
The Leukaemia Foundation welcomes Federal Labor’s commitment of $20 million to give Australian blood cancer patients faster access to leading clinical trial drugs and therapies through a new Right to Trial program.
Leukaemia Foundation CEO Bill Petch today joined Opposition Leader Bill Shorten and Shadow Health Minister for Health and Medicare Catherine King at
South Australian researchers to develop cutting edge genetic testing
Tuesday, 16 April 2019
The Leukaemia Foundation is funding a cutting-edge diagnostic test that would help clinicians identify specific gene mutations to offer more effective, targeted treatments for Australians living with blood cancer.
The SA Genomics Haematology Malignancies Node will have the first of three tests available across Australia in six
CAR-T therapy receives Federal Government funding allowing young people with ALL to receive innovative treatment
Monday, 15 April 2019,
The Leukaemia Foundation has welcomed today’s announcement by Federal Health Minister Greg Hunt to list CAR-T therapy on the Medicare Benefits Schedule (MBS). The treatment will be for use in paediatric and young adult patients up to 25 years of age with B-cell precursor acute lymphoblastic leukaemia (ALL) that is refractory, in relapse post-transplant,
Welcome commitment to reduce out-of-pocket cancer costs
Friday, 05 April 2019
The Leukaemia Foundation welcomes Federal Labor’s commitment to reducing out-of-pocket costs for cancer patients as part of a $2.3 billion funding package announced in last night’s Federal Budget reply.
The announcement includes funding to remove out-of-pocket costs associated with diagnostic imaging, bulk-billed Medicare items for oncologists and specialist surgeons,